Arthritis Medication Pauses Do Not Boost Vaccine Efficacy

Holding common arthritis drugs does not improve immune response but may cause painful disease flares for many patients.

Updated on Oct. 28, 2026 in Arthritis

Arthritis Medication Pauses Do Not Boost Vaccine Efficacy

Live Poll

Is it worth pausing your regular prescribed medications to potentially improve your response to a vaccine?

A large study published in May 2024 found that pausing common arthritis medications like biologics or JAK inhibitors after a COVID-19 vaccine dose does not boost immune response. For patients with inflammatory arthritis, continuing medication instead of holding it avoids an increased risk of disease flares.

Why it matters

Many patients with inflammatory conditions previously paused their maintenance therapy in hopes of maximizing vaccine effectiveness. This research shows that the strategy does not improve antibody production while significantly elevating the risk of a painful disease flare.

A randomized, multicenter trial of 840 patients with rheumatoid, psoriatic, and axial spondylarthritis compared holding versus continuing immunomodulatory medications for 2 weeks after a booster vaccine. The results showed no significant difference in antibody levels between the two groups.

The players

University of Alabama at Birmingham

A research institution that led this multicenter trial investigating arthritis management and vaccine response.

The details

Researchers examined immunoglobulin G levels against the SARS-CoV-2 spike protein to gauge vaccine effectiveness. By comparing patients who maintained their stable regimen of TNF inhibitors, IL-17 inhibitors, abatacept, or JAK inhibitors against those who paused, they measured both immune response and symptomatic control. The findings indicate that while antibody levels increased in both groups from baseline to the 6-week mark, holding the medication offered no immunological advantage.

November 2021 to May 2024: Enrollment and vaccination period.
2 weeks: Duration for which patients in the test group held their therapy.
Week 6: Primary outcome measurement and follow-up visit.

Health Landscape

This research provides clinical clarity on a common uncertainty regarding how immunosuppressive treatments interact with immune-boosting vaccine schedules. It marks a shift away from the practice of preemptive medication pauses for supplemental COVID-19 doses.

If you have been advised to pause your arthritis medication around vaccine appointments, discuss these study results with your physician to evaluate if this remains necessary for your specific treatment plan. Monitor your symptoms closely, as patients in the study who held their therapy faced a 2.27 times higher odds of a disease flare.

The takeaway

Pausing arthritis medications for vaccination does not improve antibody response and may trigger unnecessary disease flares. Talk with your rheumatologist before changing any medication schedule to ensure your disease remains stable during your vaccination series.